Efficient control of gene expression in the hematopoietic system using a single Tet-on inducible lentiviral vector

被引:72
作者
Barde, I [1 ]
Zanta-Boussif, MA [1 ]
Paisant, S [1 ]
Leboeuf, M [1 ]
Rameau, P [1 ]
Delenda, C [1 ]
Danos, O [1 ]
机构
[1] Genethon, CNRS, UMR 8115, F-91002 Evry, France
关键词
inducible; regulation; lentiviral vector; gene therapy; hematopoietic stem cells;
D O I
10.1016/j.ymthe.2005.09.012
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
This work addresses the problem of efficient control of gene expression in the context of viral vectors, which still represents a difficult challenge. A number of lentiviral vectors incorporating the different elements of regulatable transcriptional systems have been described, but they fail to perform satisfactorily either because of a poor dynamic range of transcription levels or because they display high background activities in the uninduced state and mediocre inducer response. We report here on the systematic comparison of vector designs containing the elements of the doxycycline-inducible Tet-on system in their most advanced versions (rtTA2S-M2 transactivator and tTS(Kid) repressor). We show that a simple "all-in-one" vector can be obtained and used for efficient control of transgene expression in long-term tissue culture and in the hematopoietic system of mice following bone marrow transplantation. Using this vector, the uninduced state can be kept at background levels and induction factors of 100-fold are repeatedly obtained over months both in tissue culture and in vivo. Interestingly, the low background activity of the all-in-one vector renders the use of the tTS repressor dispensable, avoiding the problem of progressive loss of inducibility over time associated with irreversible modifications of the chromatin surrounding proviral sequences.
引用
收藏
页码:382 / 390
页数:9
相关论文
共 42 条
[1]   Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters [J].
Amendola, M ;
Venneri, MA ;
Biffi, A ;
Vigna, E ;
Naldini, L .
NATURE BIOTECHNOLOGY, 2005, 23 (01) :108-116
[2]   Engraftment of genetically modified bone marrow cells in sensitized hosts [J].
Bracy, JL ;
Iacomini, J .
MOLECULAR THERAPY, 2002, 6 (02) :252-257
[3]   A lentiviral vector encoding the human Wiskott Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice [J].
Charrier, S ;
Stockholm, D ;
Seye, K ;
Opolon, P ;
Taveau, M ;
Gross, DA ;
Bucher-Laurent, S ;
Delenda, C ;
Vainchenker, W ;
Danos, O ;
Galy, A .
GENE THERAPY, 2005, 12 (07) :597-606
[4]   Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells [J].
De Palma, M ;
Montini, E ;
Santoni de Sio, FR ;
Benedicenti, F ;
Gentile, A ;
Medico, E ;
Naldini, L .
BLOOD, 2005, 105 (06) :2307-2315
[5]  
DEUSCHLE U, 1995, MOL CELL BIOL, V15, P1907
[6]   A third-generation lentivirus vector with a conditional packaging system [J].
Dull, T ;
Zufferey, R ;
Kelly, M ;
Mandel, RJ ;
Nguyen, M ;
Trono, D ;
Naldini, L .
JOURNAL OF VIROLOGY, 1998, 72 (11) :8463-8471
[7]   Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus [J].
Favre, D ;
Blouin, V ;
Provost, N ;
Spisek, R ;
Porrot, F ;
Bohl, D ;
Marmé, F ;
Chérel, Y ;
Salvetti, A ;
Hurtrel, B ;
Heard, JM ;
Rivière, Y ;
Moullier, P .
JOURNAL OF VIROLOGY, 2002, 76 (22) :11605-11611
[8]  
Freundlieb S, 1999, J GENE MED, V1, P4, DOI 10.1002/(SICI)1521-2254(199901/02)1:1<4::AID-JGM4>3.0.CO
[9]  
2-Y
[10]   Development of ecdysone-regulated lentiviral vectors [J].
Galimi, F ;
Saez, E ;
Gall, J ;
Hoong, N ;
Cho, G ;
Evans, RM ;
Verma, IM .
MOLECULAR THERAPY, 2005, 11 (01) :142-148